These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18619944)

  • 1. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.
    Tanabe K; Deguchi A; Higashi M; Usuki H; Suzuki Y; Uchimura Y; Kuriyama S; Ikenaka K
    Biochem Biophys Res Commun; 2008 Sep; 374(2):219-25. PubMed ID: 18619944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
    Johnson PJ; Poon TC; Hjelm NM; Ho CS; Ho SK; Welby C; Stevenson D; Patel T; Parekh R; Townsend RR
    Br J Cancer; 1999 Dec; 81(7):1188-95. PubMed ID: 10584881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry.
    Valmu L; Alfthan H; Hotakainen K; Birken S; Stenman UH
    Glycobiology; 2006 Dec; 16(12):1207-18. PubMed ID: 16880503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
    Zhang S; Jiang K; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
    Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
    Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
    Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma.
    Saitoh A; Aoyagi Y; Asakura H
    Arch Biochem Biophys; 1993 Jun; 303(2):281-7. PubMed ID: 8390218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
    Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
    J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
    Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
    Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.